Attached files
file | filename |
---|---|
8-K/A - FORM 8-K AMENDMENT NO. 1 - NEWPORT CORP | d270690d8ka.htm |
EX-23.1 - CONSENT OF KOST FORER GABBAY & KASIERER - NEWPORT CORP | d270690dex231.htm |
EX-23.2 - CONSENT OF HAYNIE & COMPANY CPAS, P.C. - NEWPORT CORP | d270690dex232.htm |
EX-23.3 - CONSENT OF FEELEY & DRISCOLL, P.C. - NEWPORT CORP | d270690dex233.htm |
EX-99.2 - FINANCIAL STATEMENTS LISTED IN ITEM 9.01(A)(II). - NEWPORT CORP | d270690dex992.htm |
EX-99.3 - PRO FORMA FINANCIAL INFORMATION LISTED IN ITEM 9.01(B). - NEWPORT CORP | d270690dex993.htm |
Exhibit 99.1
OPHIR OPTRONICS LTD.
INTERIM CONSOLIDATED FINANCIAL STATEMENTS
AS OF SEPTEMBER 30, 2011
UNAUDITED
U.S. DOLLAR IN THOUSANDS
INDEX
Page | ||
Consolidated Balance Sheets |
2 - 3 | |
Consolidated Statements of Comprehensive Income |
4 | |
Consolidated Statements of Cash Flows |
5 - 7 | |
Notes to Interim consolidated financial statements |
8 - 17 |
- 1 -
OPHIR OPTRONICS LTD.
CONSOLIDATED BALANCE SHEETS
September 30, 2011 |
December 31, 2010 |
|||||||
Unaudited | Audited | |||||||
U.S. dollars in thousands | ||||||||
ASSETS |
||||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
22,507 | 15,084 | ||||||
Short-term deposits |
114 | 93 | ||||||
Trade receivables |
20,603 | 18,945 | ||||||
Other accounts receivable |
2,618 | 2,194 | ||||||
Inventories |
27,127 | 24,182 | ||||||
Financial derivatives |
688 | 1,323 | ||||||
|
|
|
|
|||||
73,657 | 61,821 | |||||||
|
|
|
|
|||||
NON-CURRENT ASSETS: |
||||||||
Other receivables |
748 | 734 | ||||||
Financial derivatives for marketable debenture hedges |
625 | 1,153 | ||||||
Prepaid operating lease expenses of land |
114 | 117 | ||||||
Employee benefit assets |
902 | 775 | ||||||
Fixed assets |
39,434 | 37,363 | ||||||
Intangible assets |
12,506 | 11,038 | ||||||
Goodwill |
5,631 | 5,631 | ||||||
Deferred taxes |
766 | 1,065 | ||||||
|
|
|
|
|||||
60,726 | 57,876 | |||||||
|
|
|
|
|||||
134,383 | 119,697 | |||||||
|
|
|
|
The accompanying notes are an integral part of the interim consolidated financial statements.
- 2 -
OPHIR OPTRONICS LTD.
CONSOLIDATED BALANCE SHEETS
September 30, 2011 |
December 31, 2010 |
|||||||
Unaudited | Audited | |||||||
U.S. dollars in thousands | ||||||||
LIABILITIES AND EQUITY |
||||||||
CURRENT LIABILITIES: |
||||||||
Credit from banks and others |
2,499 | 2,497 | ||||||
Current maturities of marketable debentures |
4,628 | 4,664 | ||||||
Trade payables |
7,865 | 7,711 | ||||||
Current taxes payable |
674 | 860 | ||||||
Other accounts payable |
9,999 | 8,827 | ||||||
Financial derivatives |
644 | 293 | ||||||
|
|
|
|
|||||
26,309 | 24,852 | |||||||
|
|
|
|
|||||
NON-CURRENT LIABILITIES: |
||||||||
Loans from banks |
5,449 | 6,751 | ||||||
Marketable debentures |
4,628 | 6,996 | ||||||
Stock options |
| 1,048 | ||||||
Financial derivatives |
| 49 | ||||||
Other non-current liabilities |
2,019 | 2,261 | ||||||
Employee benefit liabilities |
435 | 299 | ||||||
Deferred taxes |
1,939 | 1,797 | ||||||
|
|
|
|
|||||
14,470 | 19,201 | |||||||
|
|
|
|
|||||
EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY: |
||||||||
Share capital |
10,243 | 9,575 | ||||||
Share premium |
44,736 | 27,342 | ||||||
Reserve for share-based payment transactions |
996 | 2,274 | ||||||
Retained earnings |
36,720 | 34,510 | ||||||
Reserve for hedges |
(246 | ) | 661 | |||||
Reserve for transactions with non-controlling interests |
(200 | ) | | |||||
Foreign currency translation adjustments |
64 | 28 | ||||||
|
|
|
|
|||||
92,313 | 74,390 | |||||||
Non-controlling interests |
1,291 | 1,254 | ||||||
|
|
|
|
|||||
Total equity |
93,604 | 75,644 | ||||||
|
|
|
|
|||||
134,383 | 119,697 | |||||||
|
|
|
|
The accompanying notes are an integral part of the interim consolidated financial statements.
- 3 -
OPHIR OPTRONICS LTD.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Nine months ended September 30, |
||||||||
2011 | 2010 | |||||||
Unaudited | ||||||||
U.S. dollars in thousands (except per share data) |
||||||||
Revenues from sales |
90,733 | 76,703 | ||||||
Cost of sales |
53,742 | **) 46,328 | ||||||
|
|
|
|
|||||
Gross profit |
36,991 | 30,375 | ||||||
|
|
|
|
|||||
Research and development expenses, net |
6,659 | *) 6,229 | ||||||
Selling and marketing expenses |
9,626 | **) 8,139 | ||||||
General and administrative expenses |
10,555 | *) 8,398 | ||||||
Other expenses, net |
1,339 | *) 247 | ||||||
|
|
|
|
|||||
28,179 | 23,013 | |||||||
|
|
|
|
|||||
Operating income |
8,812 | 7,362 | ||||||
Finance income |
455 | 219 | ||||||
Finance expenses |
(1,742 | ) | (1,057 | ) | ||||
Gain (loss) from revaluation of stock options |
(3,449 | ) | 29 | |||||
|
|
|
|
|||||
Income before taxes on income |
4,076 | 6,553 | ||||||
Taxes on income |
1,708 | **) 923 | ||||||
|
|
|
|
|||||
Net income |
2,368 | 5,630 | ||||||
|
|
|
|
|||||
Other comprehensive income (loss) (after tax effect): |
||||||||
Gain (loss) from cash flow hedges |
(907 | ) | 130 | |||||
Foreign currency translation adjustments |
93 | 63 | ||||||
|
|
|
|
|||||
Total other comprehensive income (loss) |
(814 | ) | 193 | |||||
|
|
|
|
|||||
Total comprehensive income |
1,554 | 5,823 | ||||||
|
|
|
|
|||||
Net income attributable to: |
||||||||
Equity holders of the Company |
2,210 | 5,497 | ||||||
Non-controlling interests |
158 | 133 | ||||||
|
|
|
|
|||||
2,368 | 5,630 | |||||||
|
|
|
|
|||||
Total comprehensive income attributable to: |
||||||||
Equity holders of the Company |
1,339 | 5,618 | ||||||
Non-controlling interests |
215 | 205 | ||||||
|
|
|
|
|||||
1,554 | 5,823 | |||||||
|
|
|
|
|||||
Net earnings per share attributable to equity holders of the Company (in U.S. dollars): |
||||||||
Basic and diluted net earnings |
0.08 | 0.21 | ||||||
|
|
|
|
*) | Reclassified. |
**) | Restated, see note 4. |
The accompanying notes are an integral part of the interim consolidated financial statements.
- 4 -
OPHIR OPTRONICS LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine months ended September 30, |
||||||||
2011 | 2010 | |||||||
Unaudited | ||||||||
U.S. dollars in thousands | ||||||||
Cash flows from operating activities: |
||||||||
Net income |
2,368 | *) 5,630 | ||||||
|
|
|
|
|||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Adjustments to the profit or loss items: |
||||||||
Depreciation and amortization |
5,686 | *) 5,227 | ||||||
Write down of prepaid operating lease expenses of land |
3 | 3 | ||||||
Cost of share-based payment, net |
98 | 138 | ||||||
Finance expenses, net |
82 | 412 | ||||||
Loss from revaluation of non-current marketable debentures and financial derivatives, net |
728 | 359 | ||||||
Loss (gain) from revaluation of stock options, net |
3,449 | (29 | ) | |||||
Capital loss (gain) from sale of fixed assets |
45 | (12 | ) | |||||
Revaluation of non-current liabilities, net |
396 | (18 | ) | |||||
Taxes on income |
1,708 | *) 923 | ||||||
Change in employee benefit assets and liabilities, net |
(16 | ) | 180 | |||||
|
|
|
|
|||||
12,179 | 7,183 | |||||||
|
|
|
|
|||||
Changes in asset and liability items: |
||||||||
Decrease (increase) in trade receivables |
(1,513 | ) | 1,291 | |||||
Increase in other accounts receivable |
(604 | ) | (497 | ) | ||||
Increase in inventories |
(2,829 | ) | (134 | ) | ||||
Increase in trade payables |
63 | 250 | ||||||
Decrease in other accounts payable |
(81 | ) | (915 | ) | ||||
|
|
|
|
|||||
(4,964 | ) | (5 | ) | |||||
|
|
|
|
|||||
Cash paid and received during the period for: |
||||||||
Interest paid |
(574 | ) | (435 | ) | ||||
Interest received |
131 | 25 | ||||||
Taxes paid |
(534 | ) | (1,916 | ) | ||||
Taxes received |
18 | 301 | ||||||
|
|
|
|
|||||
(959 | ) | (2,025 | ) | |||||
|
|
|
|
|||||
Net cash provided by operating activities |
8,624 | 10,783 | ||||||
|
|
|
|
*) | Restated, see note 4. |
The accompanying notes are an integral part of the interim consolidated financial statements.
- 5 -
OPHIR OPTRONICS LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine months ended September 30, |
||||||||
2011 | 2010 | |||||||
Unaudited | ||||||||
U.S. dollars in thousands | ||||||||
Cash flows from investing activities: |
||||||||
Investment in short-term deposits, net |
(14 | ) | (52 | ) | ||||
Purchase of fixed assets |
(6,669 | ) | (4,826 | ) | ||||
Acquisition of initially consolidated subsidiary (a) |
| (1,796 | ) | |||||
Investment in intangible assets |
(2,933 | ) | (1,916 | ) | ||||
Proceeds from sale of fixed assets |
476 | 26 | ||||||
|
|
|
|
|||||
Net cash used in investing activities |
(9,140 | ) | (8,564 | ) | ||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
Exercise of stock options into shares |
12,189 | 1,016 | ||||||
Dividends paid |
| (1,616 | ) | |||||
Receipt of long-term loans and liabilities |
793 | 583 | ||||||
Repayment of long-term loans and liabilities |
(2,236 | ) | (2,155 | ) | ||||
Repayment of debentures |
(2,554 | ) | (2,165 | ) | ||||
Purchase of shares from non-controlling interests |
(378 | ) | | |||||
Receipt (repayment) of short-term credit from banks and others, net |
80 | (20 | ) | |||||
|
|
|
|
|||||
Net cash provided by (used in) financing activities |
7,894 | (4,357 | ) | |||||
|
|
|
|
|||||
Exchange differences on balances of cash and cash equivalents |
45 | 46 | ||||||
|
|
|
|
|||||
Increase (decrease) in cash and cash equivalents |
7,423 | (2,092 | ) | |||||
Cash and cash equivalents at the beginning of the period |
15,084 | 15,475 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at the end of the period |
22,507 | 13,383 | ||||||
|
|
|
|
The accompanying notes are an integral part of the interim consolidated financial statements.
- 6 -
OPHIR OPTRONICS LTD.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine months ended September 30, |
||||||||
2011 | 2010 | |||||||
Unaudited | ||||||||
U.S. dollars in thousands | ||||||||
(a) Acquisition of initially consolidated subsidiary: |
||||||||
Subsidiarys assets and liabilities at date of acquisition: |
||||||||
Working capital (excluding cash and cash equivalents) |
| (6 | ) | |||||
Non-current receivables |
| (6 | ) | |||||
Fixed assets |
| (16 | ) | |||||
Intangible assets |
| *) (1,390 | ) | |||||
Goodwill |
| *) (1,192 | ) | |||||
Payables for acquisition |
| 66 | ||||||
Contingent liability on acquisition |
| 270 | ||||||
Deferred taxes |
| *) 478 | ||||||
|
|
|
|
|||||
| (1,796 | ) | ||||||
|
|
|
|
|||||
(b) Significant non-cash activities: |
||||||||
Settlement of stock options into shares for investor against share premium |
4,921 | | ||||||
|
|
|
|
|||||
Purchase of fixed and intangible assets on credit |
| 56 | ||||||
|
|
|
|
*) | Restated, see note 4. |
The accompanying notes are an integral part of the interim consolidated financial statements.
- 7 -
OPHIR OPTRONICS LTD.
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1:- GENERAL
These financial statements have been prepared in a condensed format as of September 30, 2011 and for the nine month period then ended (interim consolidated financial statements). These financial statements should be read in conjunction with the annual financial statements of Ophir Optronics Ltd. (Company) as of December 31, 2010 and for the year then ended and the accompanying notes (annual financial statements).
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES
a. | Basis of preparation of the interim consolidated financial statements: |
The interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles for the preparation of financial statements for interim periods, as prescribed in IAS 34, Interim Financial Reporting, and in accordance with the disclosure requirements of Chapter D of the Securities Regulations (Periodic and Immediate Reports), 1970.
The significant accounting policies and methods of computation adopted in the preparation of the interim consolidated financial statements are consistent with those followed in the preparation of the annual financial statements, except as noted below:
IFRS 3 (Revised)Business Combinations:
The amendments to IFRS 3 (Revised) address the following issues:
1. | Measurement of non-controlling interests: |
The amendment limits the circumstances in which it is possible to choose the measurement of non-controlling interests based on their fair value on the date of acquisition or at their proportionate share in the recognized amounts of the acquirees identifiable net assets. According to the amendment, this possibility is only available for components of non-controlling interests that are present ownership interests and entitle their holders to a pro rata share of the acquirees net assets in the event of liquidation (usually shares). In contrast, for other components of non-controlling interests (such as options that represent equity instruments of the acquiree) no such choice is available, and they are measured at fair value on the acquisition date, unless another measurement basis is required by IFRS such as IFRS 2.
The amendment is applied retrospectively from the date of original adoption of IFRS 3 (Revised).
The retrospective adoption of the amendment did not have a material effect on the Companys financial statements.
- 8 -
OPHIR OPTRONICS LTD.
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
2. | Share-based payment awards in a business combination: |
The amendment prescribes the accounting treatment in a business combination of an exchange of the acquirees share-based payment awards (whether the acquirer is obligated or chooses to exchange them) with the acquirers share-based payment awards. According to the amendment, the acquirer allocates a portion of the value of the award to the consideration for the business combination and a portion as an expense in the period following the acquisition. However, if the award expires as a result of the business combination and is exchanged for a new award, the value of the new award in accordance with IFRS 2 is recognized as an expense in the period following the acquisition and is not included as part of the consideration for the acquisition. Furthermore, if share-based payment awards are not exchanged, then, if the instruments have vested, they form part of the non-controlling interests and are measured pursuant to the provisions of IFRS 2. If the instruments have not vested, they are measured at the value that would have been used had they been granted on the acquisition date and this amount is allocated between the non-controlling interests and a post-acquisition expense.
The amendment is applied retrospectively from the date of original adoption of IFRS 3 (Revised).
The retrospective adoption of the amendment did not have a material effect on the Companys financial statements.
3. | Transition provisions for accounting for contingent consideration in a business combination that occurred prior to the adoption of IFRS 3 (Revised): |
According to the amendment, the amendments to IFRS 7, IAS 32 and IAS 39 which prescribe that contingent consideration in a business combination is within the scope of these Standards, do not apply to contingent consideration in respect of a business combination whose acquisition date preceded the date of adoption of IFRS 3 (Revised). Such contingent consideration will continue to be accounted for under the provisions of IFRS 3 prior to its amendment.
The amendment is applied retrospectively from January 1, 2011.
The retrospective adoption of the amendment did not have a material effect on the Companys financial statements.
IAS 1Presentation of Financial Statements:
According to the amendment to IAS 1, the changes between the opening and the closing balances of each component of other comprehensive income may be presented in the statement of changes in equity or in the notes accompanying the annual financial statements. Accordingly, the Company has elected to present said disclosure in the statement of changes in equity.
The amendment is applied retrospectively from January 1, 2011.
- 9 -
OPHIR OPTRONICS LTD.
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
IAS 32Financial Instruments: PresentationClassification of Rights Issues:
The amendment to IAS 32 provides that rights, options or warrants to acquire a fixed number of the Companys equity instruments for a fixed amount of any currency are classified as equity instruments if the Company offers the rights, options or warrants pro rata to all of its existing owners of the same class of its non-derivative equity instruments.
The amendment is applied retrospectively from January 1, 2011.
IAS 34Interim Financial Reporting:
Pursuant to the amendment to IAS 34, new disclosure requirements were introduced to interim financial reporting regarding the circumstances that are likely to affect the fair value of financial instruments and their classification, the transfers of financial instruments between different fair value levels and changes in the classification of financial assets.
The amendment is applied retrospectively from January 1, 2011.
The retrospective adoption of the amendment did not have a material effect on the financial statements.
b. | New IFRS Standards that have been issued but are not yet effective: |
In May 2011, the IASB issued four new Standards: IFRS 10, Consolidated Financial Statements, IFRS 11, Joint Arrangements, IFRS 12, Disclosure of Interests in Other Entities (the new Standards) and IFRS 13, Fair Value Measurement, and amended two existing Standards, IAS 27R (Revised 2011), Separate Financial Statements, and IAS 28R (Revised 2011), Investments in Associates and Joint Ventures.
The new Standards are to be applied retrospectively in financial statements for annual periods commencing on January 1, 2013 or thereafter. Earlier application is permitted. However, if the Company chooses earlier application, it must adopt all the new Standards as a package (excluding the disclosure requirements of IFRS 12 which may be adopted separately). The Standards prescribe transition provisions with certain modifications upon initial adoption.
The main provisions of the Standards and their expected effects on the Company are as follows:
IFRS 10Consolidated Financial Statements:
IFRS 10 supersedes IAS 27 regarding the accounting treatment of consolidated financial statements and includes the accounting treatment for the consolidation of structured entities previously accounted for under SIC 12, ConsolidationSpecial Purpose Entities.
- 10 -
OPHIR OPTRONICS LTD.
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
IFRS 10 does not prescribe changes to the consolidation procedures but rather modifies the definition of control for the purpose of consolidation and introduces a single consolidation model. According to IFRS 10, in order for an investor to control an investee, the investor must have power over the investee and exposure, or rights, to variable returns from the investee. Power is defined as the ability to influence and direct the investees activities that significantly affect the investors return.
According to IFRS 10, when assessing the existence of control, potential voting rights should be considered only if they are substantive, as opposed to the provisions of IAS 27 prior to its amendment which required consideration of potential voting rights only if they could be exercised immediately while disregarding managements intentions and financial ability to exercise such rights.
IFRS 10 also prescribes that an investor may have control even if it holds less than a majority of the investees voting rights (de facto control), as opposed to the provisions of the existing IAS 27 which permits a choice between two consolidation modelsthe de facto control model and the legal control model.
IFRS 10 is to be applied retrospectively in financial statements for annual periods commencing on January 1, 2013, or thereafter.
The Company is evaluating the possible impact of the adoption of IFRS 10 but is presently unable to assess the effects, if any, on its financial statements.
IAS 27RSeparate Financial Statements:
IAS 27R supersedes IAS 27 and only addresses separate financial statements. The existing guidance for separate financial statements has remained unchanged in IAS 27R.
IFRS 12Disclosure of Interests in Other Entities:
IFRS 12 prescribes disclosure requirements for the Companys investees, including subsidiaries, joint arrangements, associates and structured entities. IFRS 12 expands the disclosure requirements to include the judgments and assumptions used by management in determining the existence of control, joint control or significant influence over investees, and in determining the type of joint arrangement. IFRS 12 also provides disclosure requirements for material investees.
The required disclosures will be included in the Companys financial statements upon initial adoption of IFRS 12.
IFRS 13Fair Value Measurement:
IFRS 13 establishes guidance for the measurement of fair value, to the extent that such measurement is required according to IFRS. IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. IFRS 13 also specifies the characteristics of market participants and determines that fair value is based on the assumptions that would have been used by market participants. According to IFRS 13, fair value measurement is based on the assumption that the transaction will take place in the assets or the liabilitys principal market, or in the absence of a principal market, in the most advantageous market.
- 11 -
OPHIR OPTRONICS LTD.
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
IFRS 13 requires an entity to maximize the use of relevant observable inputs and minimize the use of unobservable inputs. IFRS 13 also includes a fair value hierarchy based on the inputs used to determine fair value as follows:
Level 1quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2inputs other than quoted market prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3unobservable inputs (valuation techniques that do not make use of observable inputs).
IFRS 13 also prescribes certain specific disclosure requirements.
The new disclosures, and the measurement of assets and liabilities pursuant to IFRS 13, are to be applied prospectively for periods commencing after the Standards effective date, in financial statements for annual periods commencing on January 1, 2013 or thereafter. Earlier application is permitted. The new disclosures will not be required for comparative data.
The appropriate disclosures will be included in the Companys financial statements upon initial adoption of IFRS 13.
The Company is evaluating the possible impact of the adoption of IFRS 13 but is presently unable to assess the effects, if any, on its financial statements.
IAS 19REmployee Benefits:
In June 2011, the IASB issued IAS 19R. The principal amendments included in IAS 19R are:
| Actuarial gains and losses will only be recognized in other comprehensive income and not carried to profit or loss. |
| The corridor approach which allowed the deferral of actuarial gains or losses has been eliminated. |
| The return on the plan assets is recognized in profit or loss based on a discount rate used to measure the employee benefit liabilities, regardless of the actual composition of the investment portfolio. |
| The distinction between short-term employee benefits and long-term employee benefits will be based on the expected settlement date and not on the date on which the employee first becomes entitled to the benefits. |
| The cost of past services arising from changes in the plan will be recognized immediately. |
IAS 19R is to be applied retrospectively in financial statements for annual periods commencing on January 1, 2013, or thereafter. Earlier application is permitted.
The Company is evaluating the possible impact of the adoption of IAS 19R but is presently unable to assess the effects, if any, on its financial statements.
- 12 -
OPHIR OPTRONICS LTD.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 3:- SIGNIFICANT EVENTS DURING THE REPORTED PERIOD
a. | In the first quarter of 2011, the Company updated the allocation of the proceeds received from the issuance of a package to a shareholder (in 2008) between liability for stock options and share premium. The update derives from correcting a parameter in the valuation of the liability for stock options due to the 2008 agreement between the company and the shareholder to adjust the exercise price for dividend distributions which was not taken into account before calculating the value of the liability. In calculating the value of the liability, with respect to the above update, income of $182 thousand relating to previous periods was carried in the first quarter of 2011 to the Statement of Comprehensive Income. Comparative figures have not been corrected in light of the fact that the correction is immaterial for all previous reporting periods since the date of issuance of the package. |
b. | On July 7, 2011, the Company signed a merger agreement with Newport Corporation, a publicly traded corporation incorporated according to the laws of the State of Nevada, USA, the shares of which are traded on NASDAQ (Newport) and with Helios Merger Sub Ltd (the Special Purpose entity), a private company incorporated in Israel which is wholly owned and controlled by Newport, pursuant to which the Special Purpose entity would be merged with and into the Company (the Merger). The closing of the Merger occurred on October 4, 2011, as discussed in Note 6 below. |
On September 4, 2011, a special general meeting of the Companys shareholders was held and approved the Merger.
c. | On September 15, 2011, an agreement was signed with a private company in Europe which is engaged in the development, engineering, marketing, sales and manufacturing of optical components and optical coatings ( the Seller) pursuant to which the Company will acquire, through a foreign subsidiary, if the transaction is completed, all of the Sellers activities for the total amount of $3 Million, of which $2 Million will be paid to the Seller at the closing of the transaction, and $1 Million will be held by the acquiring subsidiary, to ensure that the Sellers liabilities are met and that its presentations are accurate, and will be paid after the above liabilities are fulfilled at the following dates: $850 thousand one year after closing and $150 thousand two years after closing. |
- 13 -
OPHIR OPTRONICS LTD.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4:- BUSINESS COMBINATION
On May 17, 2010, the transaction to acquire all of the shares of PHOTON INC, an American private company which is engaged in the development, engineering, marketing and production of instruments in the laser measurement field, was completed through a foreign subsidiary. The transaction was accounted for using the purchase method according to IFRS 3.
Fair value as of May 17, 2010 was measured provisionally and during the fourth quarter of 2010 the Company completed the fair value measurements. The Company found that the excess of acquisition cost should be adjusted and attributed to other items.
The financial statements as of September 30, 2010, and for the nine month period then ended were restated in order to retroactively reflect the effect of the adjustments.
Below is the effect of the adjustments:
As previously reported |
Change | As presented in these financial statements |
||||||||||
unaudited | ||||||||||||
U.S. dollars in thousands | ||||||||||||
Statements of comprehensive income: |
||||||||||||
Nine months ended September 30, 2010: |
||||||||||||
Cost of sales |
46,319 | 9 | 46,328 | |||||||||
|
|
|
|
|
|
|||||||
Selling and marketing expenses |
8,120 | 19 | 8,139 | |||||||||
|
|
|
|
|
|
|||||||
Taxes on income |
938 | (15 | ) | 923 | ||||||||
|
|
|
|
|
|
|||||||
Net income |
5,643 | (13 | ) | 5,630 | ||||||||
|
|
|
|
|
|
|||||||
Statements of cash flow: |
||||||||||||
The subsidiarys assets and liabilities at the date of acquisition, May 17, 2010: |
||||||||||||
Working capital (except cash and cash equivalents) |
6 | | 6 | |||||||||
|
|
|
|
|
|
|||||||
Non-current debit balances |
6 | | 6 | |||||||||
|
|
|
|
|
|
|||||||
Fixed assets |
16 | | 16 | |||||||||
|
|
|
|
|
|
|||||||
Intangible assets |
917 | 473 | 1,390 | |||||||||
|
|
|
|
|
|
|||||||
Goodwill |
1,498 | (306 | ) | 1,192 | ||||||||
|
|
|
|
|
|
|||||||
Payables for acquisition |
(66 | ) | | (66 | ) | |||||||
|
|
|
|
|
|
|||||||
Contingent consideration on acquisition |
(270 | ) | | (270 | ) | |||||||
|
|
|
|
|
|
|||||||
Deferred tax liability |
(311 | ) | (167 | ) | (478 | ) | ||||||
|
|
|
|
|
|
- 14 -
OPHIR OPTRONICS LTD.
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
NOTE 5:- OPERATING SEGMENTS
a. | GENERAL For management purposes, the company is organized into business units, based on the products and services of its business units and has three operating segments, as follows: |
Infrared opticsDevelopment activity, manufacturing and marketing of lens assemblies and high performance optical components used in night vision systems, observation and thermal imaging in the military and civil markets and in powerful laser systems. The activity is mainly carried out by the Companys subsidiary, Ophir Optics LLC.
Laser Measurement InstrumentsDevelopment activity, manufacturing and marketing of instruments for measuring and analyzing the characteristics of various lasers and other light sources in terms of energy, power, beam profile and spectrum / wavelength. The activity is mainly carried out by the Company and its subsidiary, Ophir Spiricon LLC
OtherDevelopment and marketing of three dimensional non-contact measurement systems, through its subsidiary Optical Metrology Ltd.
Management monitors the operating results of its business units separately for making decisions about resource allocation and performance assessment.
Segment performance is evaluated based on operating income or loss which, in some cases, as explained in the table below, is measured differently than operating income or loss in the consolidated financial statements. Most of the adjustments are from setting of the effects for Actuary; and the write down of excess cost and expenses relating to employee options.
Group financing (including finance costs and finance income) and taxes on income are managed on a group basis and are not attributed to the operating segments.
Transfer prices between operating segments are on an arms length basis in a manner similar to transactions with third parties.
b. | Reporting on segments: |
Infra-red optics |
Laser Measurement Instruments |
Other | Adjustments | Total | ||||||||||||||||
Unaudited | ||||||||||||||||||||
U.S. dollars in thousands | ||||||||||||||||||||
Nine months ended September 30, 2011: |
||||||||||||||||||||
Revenues from sales |
53,131 | 31,025 | 6,494 | 83 | 90,733 | |||||||||||||||
Operating income |
2,191 | 7,945 | 207 | (1,531 | ) | 8,812 | ||||||||||||||
Finance Expenses, net |
(4,736 | ) | ||||||||||||||||||
Income Before taxes on Income |
4,076 |
- 15 -
OPHIR OPTRONICS LTD.
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
NOTE 5:- OPERATING SEGMENTS (cont)
For the nine months ended on the 30st of September 2010 | ||||||||||||||||||||
Infra-red optics |
Laser Measurement Instruments |
Other | Adjustments | Consolidated total |
||||||||||||||||
Thousands of dollars | ||||||||||||||||||||
Revenue |
||||||||||||||||||||
Total Revenue |
47,590 | 23,767 | 7,246 | (1,900 | ) | 76,703 | ||||||||||||||
Results |
||||||||||||||||||||
Sector Results |
2,452 | 4,799 | 484 | (373 | ) | 7,362 | ||||||||||||||
Financing Expenses, net |
(809 | ) | ||||||||||||||||||
Profit Before Income Taxes |
6,553 |
NOTE 6:- EVENTS AFTER BALANCE SHEET DATE
a. | On October 4, 2011, the transaction with Newport was completed. The Special Purpose entity was merged with and into the Company, each ordinary share of NIS 1 par value of the Company was converted into a right to receive $ 8.43 in cash (Merger Consideration), and all of the issued shares of the Special Purpose entity were converted into shares of the Company and are all held by Newport. As a result of the completion of the Merger, the separate existence of the Special Purpose entity has ceased, and the Company has become a private wholly-owned subsidiary of Newport. |
All of the options for the purchase of shares in the Company and the Stock Appreciation Rights were cancelled upon closing of the Merger. Options and Stock Appreciation Rights which had vested but had not been exercised as of the closing date of the Merger were converted into the right to receive the difference between the Merger Consideration and the exercise price of the options or the base price of the Stock Appreciation Rights, as the case may be, in cash (the Options Consideration).
Options and Stock Appreciation Rights which had not vested as of the closing date of the Merger were converted into the right to receive the Options Consideration according to the original vesting conditions. The Options Consideration for these options was deposited with a trustee at the closing of the Merger on October 4, 2011 and will be paid to the holders of the options and the Stock Appreciation Rights at their original vesting dates as determined at the time they were granted and subject to its conditions.
On October 4, 2011, upon completion of the Merger, the Company became a private company, however, the Company remains a reporting company within the meaning of such term in the Securities Law until full redemption of the Companys marketable debentures, (see also subparagraph b. below).
The Companys operating results for the reported period do not include transaction costs whose payment was conditioned on the completion of the transaction, in the total of approximately $ 1.74 million in respect of legal expenses and in the total of approximately $ 4 million in respect of employee bonuses.
b. | On November 15, 2011, the meeting of the Companys debenture holders accepted a special decision to approve the companys resolution to perform a full and early redemption of the debentures according to which each holder of NIS 1 par value of debentures will receive an amount equal to the value of the debentures principal accrued interest and indexation up to the date of actual redemption plus interest at a rate of 3.33%. |
- 16 -
OPHIR OPTRONICS LTD.
All holders of debentures at the end of trading on November 28, 2011, which is the record date for the early redemption, will be eligible for payment of early redemption of the debentures. The payment shall be made on December 11, 2011.
After the early redemption of debentures, the debentures will be deleted from trade on the Tel-Aviv Stock Exchange and from the stock exchange clearinghouse, and the Company will cease to be a reporting corporation.
- 17 -